私募机构风险偏好不降反升 4月近千只产品创净值新高

Group 1 - In April, despite significant fluctuations in the A-share market, the risk appetite of private equity institutions increased due to enhanced expectations of domestic policy support [1][5] - A total of 974 private equity products reached historical net value highs in April, with quantitative products accounting for 406 and non-quantitative products for 568 [2][3] - The number of registered private equity products increased for three consecutive months, with 1,170 products registered in April, reflecting a 12.18% month-on-month growth [3][6] Group 2 - The majority of registered products in April were stock strategy products, totaling 752, which accounted for 64.27% of the total [3][6] - Private equity firms are increasing their market research efforts, with 1,189 firms conducting 7,647 research visits in April, a 117.68% increase from March [3][4] - The top ten private equity firms in terms of research activity conducted over 59 visits each, indicating a strong interest in market opportunities [4] Group 3 - Private equity firms believe the current stock market is on the verge of a new qualitative change, with a reassessment of the valuation of core Chinese technology assets still ongoing [5][6] - Companies are focusing on sectors less affected by tariffs, such as internet, innovative pharmaceuticals, new consumption, and resources [3][6] - The overall market valuation is around 18x, with risk premiums at 4.0%, indicating a relatively high position historically [6][7] Group 4 - The resilience of the Chinese economy is becoming more evident amid the tariff conflict, enhancing the attractiveness of Chinese assets [6][7] - The potential for profit growth is expected to increase as macroeconomic recovery progresses, with artificial intelligence starting to show its impact on revenue [7]